CanSino Biologics Inc. (06185) Announces November 2025 Monthly Return on Movements in Securities

Bulletin Express12-03

CanSino Biologics Inc. disclosed its movements in share capital for November 2025. The company’s total authorized share capital stood at RMB247,043,801 at the end of the reporting period, with no change in the number of authorized H shares, which remained at 132,670,900.

The authorized A shares decreased from 114,778,999 to 114,372,901. The issued H shares were unchanged at 132,670,900, while the issued A shares remained at 114,372,901 after the cancellation of 406,098 treasury shares. As of the end of the month, there were no remaining treasury shares.

Regarding share-based plans, an H Share Option Scheme approved on 23 October 2025 has 860,000 options outstanding under H shares. Additionally, a Restricted A Share Incentive Scheme granted 2,054,600 restricted shares on 27 October 2025 at RMB41.20 per share, with no new issuance or transfer of treasury shares reported in November 2025.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1154122162?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-03 16:50","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1154122162","market":"hk","top_or_hot":-1,"title":"CanSino Biologics Inc. (06185) Announces November 2025 Monthly Return on Movements in Securities","media":"Bulletin Express","content":"<p>CanSino Biologics Inc. disclosed its movements in share capital for November 2025. The company’s total authorized share capital stood at RMB247,043,801 at the end of the reporting period, with no change in the number of authorized H shares, which remained at 132,670,900.</p>\n<p>The authorized A shares decreased from 114,778,999 to 114,372,901. The issued H shares were unchanged at 132,670,900, while the issued A shares remained at 114,372,901 after the cancellation of 406,098 treasury shares. As of the end of the month, there were no remaining treasury shares.</p>\n<p>Regarding share-based plans, an H Share Option Scheme approved on 23 October 2025 has 860,000 options outstanding under H shares. Additionally, a Restricted A Share Incentive Scheme granted 2,054,600 restricted shares on 27 October 2025 at RMB41.20 per share, with no new issuance or transfer of treasury shares reported in November 2025.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CanSino Biologics Inc. (06185) Announces November 2025 Monthly Return on Movements in Securities</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCanSino Biologics Inc. (06185) Announces November 2025 Monthly Return on Movements in Securities\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-12-03 16:50</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>CanSino Biologics Inc. disclosed its movements in share capital for November 2025. The company’s total authorized share capital stood at RMB247,043,801 at the end of the reporting period, with no change in the number of authorized H shares, which remained at 132,670,900.</p>\n<p>The authorized A shares decreased from 114,778,999 to 114,372,901. The issued H shares were unchanged at 132,670,900, while the issued A shares remained at 114,372,901 after the cancellation of 406,098 treasury shares. As of the end of the month, there were no remaining treasury shares.</p>\n<p>Regarding share-based plans, an H Share Option Scheme approved on 23 October 2025 has 860,000 options outstanding under H shares. Additionally, a Restricted A Share Incentive Scheme granted 2,054,600 restricted shares on 27 October 2025 at RMB41.20 per share, with no new issuance or transfer of treasury shares reported in November 2025.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06185","symbol_name":"康希诺生物","start_time":0,"source_url":"","article_id":"1154122162","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1154122162","pubTimestamp":1764751844,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"CanSino Biologics Inc. disclosed its movements in share capital for November 2025. The company’s total authorized share capital stood at RMB247,043,801 at the end of the reporting period, with no...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06185":"康希诺生物"},"translate_title":"康希诺生物股份公司(06185)公布2025年11月证券变动月报表","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06185":1},"content_text":"CanSino Biologics Inc. disclosed its movements in share capital for November 2025. The company’s total authorized share capital stood at RMB247,043,801 at the end of the reporting period, with no change in the number of authorized H shares, which remained at 132,670,900.\nThe authorized A shares decreased from 114,778,999 to 114,372,901. The issued H shares were unchanged at 132,670,900, while the issued A shares remained at 114,372,901 after the cancellation of 406,098 treasury shares. As of the end of the month, there were no remaining treasury shares.\nRegarding share-based plans, an H Share Option Scheme approved on 23 October 2025 has 860,000 options outstanding under H shares. Additionally, a Restricted A Share Incentive Scheme granted 2,054,600 restricted shares on 27 October 2025 at RMB41.20 per share, with no new issuance or transfer of treasury shares reported in November 2025.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"shareholding,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.10","shortVersion":"4.35.10","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1154122162","isCrawlerRequest":true}